Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 611,071Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 42Eli Lilly

02 1ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

02

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

03

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

04

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

05

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

06

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2022-05-13

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

07

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

08

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

09

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

10

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

11

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

12

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-07-28

Application Number : 215866

Regulatory Info : RX

Registration Country : USA

blank

13

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

14

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

15

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

16

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

17

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

18

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Packaging :

Approval Date : 2023-11-08

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

19

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank

20

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

TIRZEPATIDE

Brand Name : ZEPBOUND

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Packaging :

Approval Date : 2024-03-28

Application Number : 217806

Regulatory Info : RX

Registration Country : USA

blank